Antiplatelet and/or anticoagulant agents (collectively known as antithrombotic agents) are
used to reduce the risk of thromboembolic events in patients with conditions such as atrial …

We conducted systematic reviews of predefined clinical questions and used the Grading of
Recommendations, Assessment, Development and Evaluations approach to develop …

Background: The increasing use of anticoagulant therapy and anti‐platelet agents in the
primary and secondary prevention of cardiovascular, cerebrovascular and venous …

Endoscopic procedure is commonly used to make diagnosis or therapy. Endoscopy has risk
on the procedure or after the procedure. Patient with antithrombotic therapy, both antiplatelet …

Opinion statement Management of patients on anticoagulant or antiplatelet therapy
undergoing endoscopy presents a balance of risks between haemorrhage due to the …

A large number of patients worldwide receive anticoagulant and antiplatelet agents,
collectively known as antithrombotic agents. Several new anticoagulants and antiplatelet …

The role of endoscopic procedures, in both diagnostic and therapeutic purposes is
continually expanding and evolving rapidly. In this context, endoscopists will encounter …

Antithrombotic-associated gastrointestinal (GI) bleeding is an increasing burden due to the
growing population of advanced age, with multiple medical comorbidities, and the use of …

In der Therapie kardiovaskulärer Erkrankungen sind orale Antikoagulantien (AC) und
Thrombozytenfunktionshemmer (TFH) weit verbreitet. Wird bei Patienten, die solche …

Antiplatelet agents and anticoagulants make up the larger group of antithrombotic
medications, which have seen increasing use worldwide as populations in developed …